Etao International Co., Ltd. (ETAOF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.50: the stock has moved about 50% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerEtao International Co., Ltd. (ETAOF) trades at $0.0001. ETAO International Co., Ltd. operates a comprehensive digital healthcare ecosystem, integrating virtual telemedicine, AI analytics, online insurance, pharmaceuticals, biotechnology, and physical clinics. Sector: Healthcare.
Price as of · Last analyzed: Jun 14, 2026Analyst Coverage for ETAOF: ETAOF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Etao International Co., Ltd. (ETAOF) Healthcare & Pipeline Overview
ETAO International Co., Ltd. is a digital healthcare provider establishing a comprehensive ecosystem encompassing virtual telemedicine, AI-driven analytics, online insurance, pharmaceuticals, and physical clinics. The company, founded in 2020, aims to integrate diverse medical services within the evolving healthcare technology landscape.
What Is the Investment Thesis for ETAOF?
ETAO International Co., Ltd. is positioned within the growing digital healthcare sector, leveraging a comprehensive ecosystem that includes telemedicine, AI, online insurance, and physical clinics. A key value driver is the increasing global demand for telehealth services, which the company actively addresses through its virtual consultation offerings. The integration of AI and big data analytics presents an opportunity for enhanced operational efficiency and personalized patient care, potentially improving service quality and scalability. However, the company's financial profile, marked by a significant negative profit margin of -1544.4% and a gross margin of 32.7%, indicates substantial operational challenges and a current lack of profitability. Its listing on the OTC Other tier introduces risks related to limited regulatory oversight, potentially lower liquidity, and less stringent disclosure requirements, as highlighted by its 'Unknown' disclosure status. Investors should monitor the company's ability to achieve profitability, execute its multi-faceted business plan, and navigate the complexities of the OTC market while scaling its diverse healthcare offerings.
Based on FMP financials and quantitative analysis
ETAOF Key Highlights
Market Capitalization is $0.00B, indicating a micro-cap or unvalued status.
- Profit Margin stands at -1544.4%, reflecting significant unprofitability.
- Gross Margin is 32.7%, suggesting some efficiency in core operations before overheads.
- Beta of 1.50 indicates higher volatility compared to the broader market.
- The company employs 3600 individuals, supporting its comprehensive healthcare ecosystem.
Who Are ETAOF's Competitors?
ETAOF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | $0.94 | +6.93% | — | |
| CCM Concord Medical Services Holdings Limited | $3.80 | -6.40% | — | |
| DCGO DocGo Inc. | $0.29 | +6.34% | $28.6M | — |
| CCEL Cryo-Cell International, Inc. | $5.01 | +12.46% | $40.4M | — |
| BTMD biote Corp. | $1.13 | +5.61% | $49.8M | — |
| AIRS AirSculpt Technologies, Inc. | $1.18 | -1.67% | $85.1M | — |
| JYNT The Joint Corp. | $7.28 | +1.04% | $103M | — |
| AUNA Auna S.A. | $4.99 | -3.29% | $369M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ETAOF's Key Strengths?
Comprehensive digital healthcare ecosystem integrating diverse services.
- Focus on virtual telemedicine, aligning with growing market demand.
- Utilization of advanced AI and big data analytics for healthcare solutions.
- Presence in both online insurance and pharmaceutical provisions, diversifying offerings.
What Are ETAOF's Weaknesses?
Significant negative profit margin of -1544.4%, indicating substantial unprofitability.
- Listing on the OTC Other tier, implying potentially limited regulatory oversight and liquidity.
- Disclosure status is 'Unknown', hindering investor transparency.
- Company's market position and key revenue drivers require further investigation (as per AI insight).
What Are the Key Risks for ETAOF?
Significant negative profit margin of -1544.4% indicates substantial operational challenges and a lack of profitability, posing a risk to long-term sustainability.
- The 'Unknown' disclosure status and OTC Other listing present risks related to limited transparency, regulatory oversight, and potential difficulty in obtaining reliable financial information.
- Intense competition within the digital healthcare sector from well-capitalized and established players could hinder market share growth and profitability.
- Execution risk associated with managing a diverse and complex healthcare ecosystem, including virtual, AI, insurance, pharma, biotech, and physical components.
- Potential for limited liquidity and high price volatility due to its OTC Other market listing, making it challenging for investors to trade shares efficiently.
What Are ETAOF's Competitive Advantages?
- Comprehensive integrated ecosystem spanning virtual, AI, insurance, pharma, biotech, and physical care.
- Early mover advantage in integrating diverse digital and traditional healthcare services.
- Leveraging AI and big data for potentially enhanced diagnostic and operational efficiencies.
- Headquartered in New York City, providing access to a major financial and healthcare hub.
- Broad service portfolio potentially creating customer stickiness through bundled offerings.
What Does ETAOF Do?
ETAO International Co., Ltd., established in 2020 and headquartered in New York, New York, operates within the dynamic digital healthcare sector. The company has strategically developed a comprehensive healthcare ecosystem designed to deliver a wide array of medical services. This ecosystem is built upon several interconnected pillars, starting with virtual telemedicine consultations, which provide remote access to medical professionals and are a cornerstone of modern digital health. Complementing these virtual services, ETAO leverages advanced artificial intelligence (AI) and big data analytics to enhance diagnostic capabilities, personalize patient care, and optimize operational efficiencies across its network. The company also extends its offerings to include online insurance solutions, aiming to streamline access to healthcare coverage and financial services for its users. Furthermore, ETAO is involved in pharmaceutical provisions, ensuring access to necessary medications, and is actively engaged in biotechnology initiatives, suggesting a focus on innovative medical research and development. This integrated approach is further solidified by a network of both physical hospitals and specialized clinics, which provide traditional in-person care and serve as crucial touchpoints within its broader digital framework. This multi-faceted strategy positions ETAO International Co., Ltd. as a holistic provider in the digital healthcare space, seeking to bridge the gap between virtual and physical medical services while leveraging technological advancements to improve healthcare delivery.
What Products and Services Does ETAOF Offer?
- Operates a comprehensive digital healthcare ecosystem.
- Provides virtual telemedicine consultations for remote medical access.
- Utilizes advanced artificial intelligence and big data analytics for healthcare insights.
- Offers online insurance solutions to streamline healthcare coverage.
- Engages in pharmaceutical provisions, supplying necessary medications.
- Undertakes biotechnology initiatives, focusing on medical research and development.
- Manages a network of physical hospitals for inpatient and specialized care.
- Operates specialized clinics for outpatient and focused medical services.
How Does ETAOF Make Money?
- Generates revenue from fees for virtual telemedicine consultations and related digital health services.
- Derives income from online insurance offerings, potentially through commissions or direct policy sales.
- Sells pharmaceuticals and medical products through its provisions segment.
- Monetizes biotechnology initiatives through potential licensing, partnerships, or product development.
- Earns revenue from services provided at its network of physical hospitals and specialized clinics.
What Industry Does ETAOF Operate In?
ETAO International Co., Ltd. operates within the rapidly evolving digital healthcare sector, a segment characterized by significant technological innovation and increasing consumer adoption of virtual services. The broader healthcare industry is experiencing a transformative shift towards integrated, patient-centric models, with a strong emphasis on telehealth, AI-driven diagnostics, and data analytics for personalized medicine. ETAO's comprehensive ecosystem, encompassing virtual consultations, AI, online insurance, and physical facilities, positions it to capitalize on these trends. The competitive landscape is fragmented, featuring established healthcare providers, technology giants entering the health space, and numerous specialized digital health startups. While the demand for telehealth is a significant tailwind, ETAO must differentiate itself through service quality, technological integration, and effective market penetration, especially given its relatively recent establishment in 2020.
Who Are ETAOF's Key Customers?
- Individual patients seeking convenient and accessible medical care.
- Consumers looking for integrated online insurance solutions.
- Healthcare providers and institutions seeking AI-driven analytics and data solutions.
- Patients requiring pharmaceutical products and specialized medical treatments.
- Individuals utilizing both virtual and physical healthcare services within ETAO's ecosystem.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Etao International Co., Ltd. operates in the Healthcare sector. It is headquartered in New York, US. The company is led by CEO Wen Sheng Liu. ETAOF has traded publicly since 2023.
Financial Health
Etao International Co., Ltd.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
ETAOF Financials
ETAOF Latest News
No recent news available for ETAOF.
ETAOF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ETAOF.
Price Targets
Wall Street price target analysis for ETAOF.
ETAOF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ETAOF; grades run from A+ (80-100) to F (below 30).
Leadership: Wensheng Liu
CEO
Wensheng Liu serves as the CEO of ETAO International Co., Ltd., overseeing a workforce of 3600 employees. His leadership is central to the company's strategy of building a comprehensive digital healthcare ecosystem.
Track Record: Under Wensheng Liu's leadership, ETAO International Co., Ltd. was established in 2020 and has since developed a broad and integrated healthcare ecosystem. His strategic decisions have guided the company's expansion into diverse medical services, including virtual consultations and AI-driven solutions. The company's current structure, encompassing both digital and physical healthcare assets, reflects the strategic direction set during his tenure.
ETAOF OTC Market Information
ETAO International Co., Ltd. trades on the OTC Other tier, which is the lowest of the three primary OTC market tiers. This tier includes companies that do not meet the minimum financial or disclosure requirements for OTCQX or OTCQB, or those that have chosen not to provide adequate current information to OTC Markets Group. Unlike major exchanges such as NYSE or NASDAQ, which have stringent listing standards regarding financial health, corporate governance, and reporting, OTC Other has minimal requirements. This often results in less transparency and higher risk for investors.
- OTC Tier: OTC Other
- Limited regulatory oversight compared to major exchanges, potentially exposing investors to higher risks.
- Lower transparency due to 'Unknown' disclosure status, making it difficult to assess financial health and operations.
- Potentially limited liquidity, leading to wider bid-ask spreads and difficulty in trading shares.
- Increased susceptibility to market manipulation and speculative trading due to less stringent reporting.
- Difficulty in obtaining reliable information and analyst coverage, complicating investment decisions.
- Verify the company's most recent financial statements and audit reports, if available.
- Examine any public filings or disclosures made to understand operational performance.
- Research the management team's background and track record beyond what is publicly stated.
- Assess the company's business model for sustainability and competitive advantages.
- Investigate any legal or regulatory actions against the company or its executives.
- Analyze trading volume and bid-ask spread to understand potential liquidity challenges.
- Seek independent research or news articles for third-party perspectives on the company.
- Headquartered in New York City, suggesting a presence in a major business hub.
- Reported employee count of 3600, indicating a substantial operational scale.
- Stated focus on a comprehensive healthcare ecosystem, aligning with a legitimate business model.
- Involvement in diverse areas like telemedicine, AI, pharma, and physical clinics, suggesting active operations.
What Investors Ask About Etao International Co., Ltd. (ETAOF) — Healthcare
How does ETAO International Co., Ltd. leverage technology in its healthcare ecosystem?
ETAO International Co., Ltd. places technology at the core of its healthcare ecosystem to enhance service delivery and operational efficiency.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is strictly limited to provided source data. Lack of detailed financial history, specific market share data, or analyst coverage means certain sections are generalized or reflect the 'Unknown' status where applicable.
- CEO background and track record are limited to the provided information, which is not extensive.